• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Dihydroergotamine Mesylate

CAS No. 6190-39-2

Dihydroergotamine Mesylate ( (+)-Dihydroergotamine )

产品货号. M15343 CAS No. 6190-39-2

Dihydroergotamine mesylate is an ergot alkaloid used to treat migraines.

纯度: >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
50MG ¥617 有现货
100MG 获取报价 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Dihydroergotamine Mesylate
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Dihydroergotamine mesylate is an ergot alkaloid used to treat migraines.
  • 产品描述
    Dihydroergotamine mesylate is an ergot alkaloid used to treat migraines.
  • 同义词
    (+)-Dihydroergotamine
  • 通路
    Endocrinology/Hormones
  • 靶点
    5-HT Receptor
  • 受体
    5-HT
  • 研究领域
    Neurological Disease
  • 适应症
    ——

化学信息

  • CAS Number
    6190-39-2
  • 分子量
    679.80
  • 分子式
    C34H41N5O8S
  • 纯度
    >98%(HPLC)
  • 溶解度
    DMSO: 100 mM
  • SMILES
    O=C([C@@H](CN(C)[C@]1([H])C2)C[C@]1([H])C3=C4C2=CNC4=CC=C3)N[C@](C(N5[C@H]6CC7=CC=CC=C7)=O)(C)O[C@@]5(O)[C@]8([H])CCCN8C6=O.OS(=O)(C)=O
  • 化学全称
    (2R,4R,7R)-N-[(1S,2S,4R,7S)-7-Benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo-[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide mesylate

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Colman I, et al. Ann Emerg Med, 2005. 45(4): p. 393-40
产品手册
关联产品
  • AVN-101

    A higly potent, orally bioavailable, BBB permeable 5-HT7 receptor antagonist with Ki of 153 pM, with slightly lesser potency toward 5-HT6, 5-HT2A and 5HT-2C (Ki=1.2-2.0 nM).

  • DSP-1053

    DSP-1053 is a novel potent serotonin reuptake (SERT) inhibitor with 5-HT1A partial agonistic activity that binds to human serotonin transporter and 5-HT1A receptor with Ki of 1.02 and 5.05 nM, respectively.

  • SB1317

    SB1317 is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3).